Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Prevail Therapeutics, Oncocyte, Baidu: 5 Top Stock Gainers for Tuesday
By Rob Lenihan
Dec 15, 2020 2:14 PM EST
PRESS RELEASES
Oncocyte Announces Pricing Of $35 Million Public Offering Of Common Stock
By GlobeNewswire
Feb 5, 2021 8:25 AM EST
PRESS RELEASES
Oncocyte Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Feb 4, 2021 4:05 PM EST
PRESS RELEASES
Oncocyte Announces Definitive Agreement To Acquire Chronix Biomedical, Inc.
By GlobeNewswire
Feb 2, 2021 8:00 AM EST
PRESS RELEASES
Oncocyte To Present New Data At The IASLC 2020 World Conference On Lung Cancer
By GlobeNewswire
Jan 28, 2021 8:00 AM EST
PRESS RELEASES
Oncocyte Announces $25 Million Registered Offering
By GlobeNewswire
Jan 20, 2021 4:08 PM EST
PRESS RELEASES
Oncocyte To Present At The 23rd Annual Needham Virtual Growth Conference
By GlobeNewswire
Jan 12, 2021 6:21 PM EST
INVESTING
Prevail Therapeutics, Oncocyte, Baidu: 5 Top Stock Gainers for Tuesday
By Rob Lenihan
Dec 15, 2020 2:14 PM EST
INVESTING
Oncocyte Soars on Licensing Deal With Chinese Firm
By Dan Weil
Dec 15, 2020 10:48 AM EST
PRESS RELEASES
Oncocyte To Present At The 15th Annual LD Micro Main Event
By GlobeNewswire
Dec 15, 2020 8:10 AM EST
PRESS RELEASES
Oncocyte Corporation Hosting Key Opinion Leader Call On Proprietary Molecular Tests For Cancer Treatment Selection
By GlobeNewswire
Dec 7, 2020 4:05 PM EST
PRESS RELEASES
Oncocyte To Participate At 32nd Annual Piper Sandler Virtual Healthcare Conference
By GlobeNewswire
Nov 18, 2020 4:05 PM EST
PRESS RELEASES
Oncocyte To Present DetermaIO™ Test Data At The 2020 Society For Immunotherapy Of Cancer (SITC) Conference
By GlobeNewswire
Nov 9, 2020 4:05 PM EST
PRESS RELEASES
Oncocyte To Report Third Quarter 2020 Financial Results On Thursday, November 12
By GlobeNewswire
Nov 2, 2020 8:00 AM EST
PRESS RELEASES
Oncocyte Named One Of The 2020 Best Places To Work In Orange County In Its First Year In Irvine, CA
By GlobeNewswire
Oct 28, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte And Fondazione Michelangelo, A Leading Non-Profit Cancer Research Foundation, Announce Immune Therapy Biomarker Collaboration
By GlobeNewswire
Oct 8, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte Agrees To Enter Licensing And Collaboration Agreement With Chronix Biomedical
By GlobeNewswire
Oct 1, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte To Participate At The Lake Street Capital Markets 4th Annual Best Ideas Growth Conference
By GlobeNewswire
Sep 14, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte And The Guardian Research Network® Announce Strategic Alliance
By GlobeNewswire
Sep 3, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte Announces Addition Of Experienced Healthcare Executive, Jennifer Carter, MD, MPH, MBA To Board Of Directors
By GlobeNewswire
Aug 27, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte To Participate At Needham Virtual Cancer Diagnostics Conference
By GlobeNewswire
Aug 13, 2020 4:05 PM EDT
PRESS RELEASES
Oncocyte To Hold KOL Webinar Highlighting Clinical Data On Its DetermaIO™ Test For Immunotherapy Response Prediction
By GlobeNewswire
Aug 11, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte Announces Rapid Adoption Of DetermaRx™ In Community Health Systems
By GlobeNewswire
Jul 28, 2020 8:00 AM EDT
PRESS RELEASES
Oncocyte To Hold KOL Webinar Showcasing New Data And Real World Usage Of DetermaRx™
By GlobeNewswire
Jul 23, 2020 4:05 PM EDT
PRESS RELEASES
Oncocyte To Report Second Quarter 2020 Financial Results On Wednesday, July 29
By GlobeNewswire
Jul 20, 2020 4:05 PM EDT
